✦ LIBER ✦

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

✍ Scribed by David Rossi; Donatella Dennetta; Marcello Ugolini; Vincenzo Catalano; Paolo Alessandroni; Paolo Giordani; Anna Maria Baldelli; Virginia Casadei; Francesco Graziano; S. Luzi Fedeli

Book ID: 107384401
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 129 KB
Volume: 5
Category: Article
ISSN: 1776-2596
DOI: 10.1007/s11523-010-0163-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of weekly chemotherapy

A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

Phase I/II trial of docetaxel and carbop

Phase I/II trial of docetaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

✍ Akira Shoji; Takashi Ogura; Kaneo Suzuki; Hiroshi Takahashi; Kenichi Takahashi; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 67 KB

Phase II clinical trial with gemcitabine

Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

✍ Vega Iranzo; Rafael Sirera; Alfredo Carrato; Andrea Cabrera; Eloísa Jantus; Rica 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 314 KB

A randomized phase II trial of amonafide

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group

✍ Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mai 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Phase I/II Trial of Docetaxel and Carbop

Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

Phase II study of weekly chemotherapy wi

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 330 KB